— Know what they know.
Not Investment Advice
Also trades as: ASBP (NASDAQ) · $vol 6M

ASBPW NASDAQ

Aspire Biopharma Holdings, Inc.
1W: -9.1% 1M: -1.6% 3M: +25.9% YTD: -3.2% 1Y: -52.0%
$0.02
+0.00 (+35.34%)
 
Weekly Expected Move ±57.1%
$-0 $0 $0 $0 $0
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 41 · $207033 mcap · 10M float · 0.209% daily turnover · Short 48% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.2M
52W Range0.0116-0.045
Volume0
Avg Volume21,501
Beta0.15
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOKraig T. Higginson
Employees2
SectorHealthcare
IndustryBiotechnology
IPO Date2022-04-11
23150 Fashion Drive
Estero, FL 33928
US
415 592 7399
About Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc. operates as a biotechnology enterprise primarily focused on innovative diagnostic approaches and molecular analysis. The company's core mission involves engineering remarkably precise testing tools for the identification of various illnesses, utilizing breakthroughs in genetic and biochemical science to serve the needs of the healthcare and life science sectors.

Recent Insider Trades

NameTypeSharesPriceDate
Fell Donald G. P-Purchase 10,500 $0.39 2025-06-05
Fell Donald G. P-Purchase 10,500 $0.39 2025-06-05
Fell Donald G. P-Purchase 9,500 $0.39 2025-06-04
Fell Donald G. P-Purchase 9,500 $0.39 2025-06-04
AJJARAPU SURENDRA K 0 — 2023-08-18

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms